Testosterone inhibits cAMP-phosphodiesterases in heart extracts from rats and increases cAMP levels in isolated left atria

Pharmacology

Volumn 87, Issue 3-4, 2011, Pages 155-160

  Bordallo, Javier ^a,b   Cantabrana, Begoña ^a,b   Suárez, Lorena ^b   Sánchez, Manuel ^a,b,c  

^a UNIVERSITY OF OVIEDO   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c Facultad de Medicina   (Spain)

Author keywords

Androgens; cAMP dependent phosphodiesterase; Chinese hamster ovary cells; Heart; Tracheal smooth muscle

Indexed keywords

5BETA ANDROSTANOLONE; ANDROSTANOLONE; CYCLIC AMP PHOSPHODIESTERASE; HEART MUSCLE EXTRACT; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CELL LEVEL; CHO CELL; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRACHEA MUSCLE;

EID: 79952106162     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324172     Document Type: Article

References (32)

1. Jones RD, Hugh Jones T, Channer KS: The influence of testosterone upon vascular reactivity. Eur J Endocrinol 2004; 151: 29-37. (Pubitemid 39117362)
2. Malkin CJ, Jones RD, Jones TH, Channer KS: Effect of testosterone on ex vivo vascular reactivity in man. Clin Sci (Lond) 2006; 111: 265-274. (Pubitemid 44599873)
3. Perusquia M, Navarrete E, Gonzalez L, Villalon CM: The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery. Life Sci 2007; 81: 993-1002. (Pubitemid 47393568)
4. Koenig H, Fan CC, Goldstone AD, Lu CY, Trout JJ: Polyamines mediate androgenic stimulation of calcium fluxes and membrane transport in rat heart myocytes. Circ Res 1989; 64: 415-426. (Pubitemid 19073796)
5. Rubin JM, Hidalgo A, Bordallo C, Cantabrana B, Sanchez M: Positive inotropism induced by androgens in isolated left atrium of rat: evidence for a cAMP-dependent transcriptional mechanism. Life Sci 1999; 65: 1035-1045. (Pubitemid 29410388)
6. Sánchez M, Secades L, Bordallo C, Meana C, Rubin JM, Cantabrana B, Bordallo J: Role of polyamines and cAMP-dependent mechanisms on 5α-dihydrotestosterone-elicited functional effects in isolated right atria of rat. J Cardiovasc Pharmacol 2009; 54: 310-318.
7. Golden KL, Marsh JD, Jiang Y, Moulden J: Acute actions of testosterone on contractile function of isolated rat ventricular myocytes. Eur J Endocrinol 2005; 152: 479-483. (Pubitemid 40439502)
8. Vicencio JM, Ibarra C, Estrada M, Chiong M, Soto D, Parra V, Diaz-Araya G, Jaimovich E, Lavandero S: Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 2006; 147: 1386-1395. (Pubitemid 43244373)
9. Vitale C, Mendelsohn ME, Rosano GM: Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009; 6: 532-542.
10. Velasco L, Sanchez M, Rubin JM, Hidalgo A, Bordallo C, Cantabrana B: Intracellular cAMP increases during the positive inotropism induced by androgens in isolated left atrium of rat. Eur J Pharmacol 2002; 438: 45-52. (Pubitemid 34242918)
11. Djoseland O, Gordeladze JO, Hoglo S, Halse JI, Haugen HN: Evidence for androgen-dependent phosphodiesterase activity in rat seminal vesicle and epididymis. Int J Androl 1980; 3: 363-366. (Pubitemid 10003473)
12. Holtz A, Brennan RG, Battista D, Terner C: Androgen control of an inhibitory modulator of phosphodiesterase in rat epididymis and prostate. Endocrinology 1981; 108: 1538-1544. (Pubitemid 11079182)
13. Sutherland DJ, Singhal RL: Alterations in adenylate cyclase activity of the rat prostate gland. Biochim Biophys Acta 1974; 343: 238-249.
14. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M: Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 2004; 145: 2253-2263. (Pubitemid 38535054)
15. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, Vannelli GB, Mancina R, Forti G, Maggi M: Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 2005; 47: 409-416. (Pubitemid 40248872)
16. 2-adrenoceptors, the polyamine system and external calcium. Eur J Pharmacol 2008; 601: 154-162.
17. MacKenzie SJ, Houslay MD: Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element- binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells. Biochem J 2000; 347: 571-578. (Pubitemid 30229406)
18. Shepherd MC, Baillie GS, Stirling DI, Houslay MD: Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells. Br J Pharmacol 2004; 142: 339-351. (Pubitemid 38746170)
19. Pugh PJ, Jones RD, West JN, Jones TH, Channer KS: Testosterone treatment for men with chronic heart failure. Heart 2004; 90: 446-447. (Pubitemid 38406925)
20. Deslypere JP, Vermeulen A: Influence of age on steroid concentrations in skin and striated muscle in women and in cardiac muscle and lung tissue in men. J Clin Endocrinol Metab 1985; 61: 648-653. (Pubitemid 16248085)
21. Kaufman J, Vermeulen A: The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005; 26: 833-876. (Pubitemid 41428540)
22. 1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats. Naunyn Schmiedebergs Arch Pharmacol 2009; 380: 421-430.
23. 2 -adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart. Br J Pharmacol 2009; 156: 62-83.
24. Galindo-Tovar A, Vargas ML, Kaumann AJ: Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4- evoked sinoatrial bradycardia in rat atrium. Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 379-384.
25. Fan Chung K: Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol 2006; 533: 110-117. (Pubitemid 43348344)
26. Spence S, Rena G, Sweeney G, Houslay MD: Induction of Ca 2+ /calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms. Biochem J 1995; 310: 975-982.
27. Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD, Alexopoulos G, Ktenas V, Rapti AC, Tsagalou EP, Nanas JN: Hormonal profile in patients with congestive heart failure. Int J Cardiol 2003; 87: 179-183. (Pubitemid 36135974)
28. Osadchii O, Norton G, Woodiwiss A: Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats. Eur J Pharmacol 2005; 514: 201-208. (Pubitemid 40720361)
29. Stehlik J, Movsesian MA: Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure. Expert Opin Investig Drugs 2006; 15: 733-742.
30. Weishaar RE, Cain MH, Bristol JA: A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem 1985; 28: 537-545. (Pubitemid 15098154)
31. Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990; 11: 150-155. (Pubitemid 20118008)
32. Wallis RM, Corbin JD, Francis SH, Ellis P: Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 1999; 83: 3C-12C. (Pubitemid 29122752)